- Visibility 140 Views
- Downloads 37 Downloads
- Permissions
- DOI 10.18231/2394-2797.2018.0021
-
CrossMark
- Citation
Method development, degradation pathway and kinetic of capecitabine
- Author Details:
-
Dhara R. Patel *
The present work describes a simple, accurate and precise Stability indicating RP-HPLC method for the estimation of Capecitabine (CPT) in bulk and pharmaceutical formulation. The Mobile phase used was Acetonitrile: Water (60: 40v/v) with 1ml/min. flow rate and 240nm was used as a wavelength maximum. The C18 HS (250 X 4.6) mm, 5 µm column was used as a stationary phase. The method was validated as per the ICHQ2 Guidelines. The retention time of CPT was found to be 3.3 min. A linear response was observed in the range of 10-50 ?g/mL with a regression coefficient of 0.999. The LOD and LOQ were found to be 1.43?g/mL and 4.34?g/mL respectively. This method can be used for the determination of CPT in quality control of API and dosage form without interference of the excipients, impurities and degradation products and hence can be used as stability indicating assay method. CPT was subjected to degradation under different stress conditions recommended by ICH viz acid, alkali, photolytic, dry heat and oxidative condition. The samples so generated were used for degradation studies including degradation kinetic study using the developed method. The degradation pathway of CPT was found to be acid hydrolysis and temperature exceeding 100°c. The degradation kinetic study shows that the acid hydrolysis, alkaline hydrolysis and oxidative degradation of the CPT follow first order kinetic.
Keywords: Anticancer drug, Capecitabine, Degradation, Stability indicating assay method, Validation.
References
- XELODA PI 110125, CDS8.0, Page no.: 1-28, Roche.
- Q1A (R2): stability testing of new drugs and products, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH harmonised tripartite guideline, 2003, 1-18.
- FDA Guideline for Submitting Samples and Analytical Data for Methods Validation.
- FDA Reviewer Guidance: Validation of Chromatographic Methods.
- FDA guideline Guidance for Industry, Analytical Procedures and Methods Validation, FDA, 2000.
- Swartz, M., Krull, I. Investigating Out-Of-Specifications Results. LCGC. 2004;22(2):132-136.
- Centre for Drug Evaluation and Research (CDER). (2006). Guidance for Industry Investigating Out-of- Specification (OOS) Test Results for Pharmaceutical Production. Accessed on April, 2011. Available from:
- Ana Paola Cione, Edivan Tonhi and Paulo Silva (2011). Stability Indicating Methods, Quality Control of Herbal Medicines and Related Areas, Prof. Yukihiro Shoyama (Ed.), ISBN: 978-953-307-682-9, InTech, Available from: http://www.intechopen.com/books/quality-control- of-herbal-medicines-and-related areas/stabilityindicating- methods. pg no.: 25- 36.
- Kapil Kalra, Method Development and Validation of Analytical Procedures, In Tech, www.intechopen.com, PAGE NO.: 1-15.
- ICH Q2A. Guidance for industry: Text on validation of analytical procedures.2011.Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplian ceRegulatoryInformation/Guidances/ucm073381.pdf
- Cartenson JT, Swarbrick J. Solution kinetics- Drug stability principles and practice; 2nd Edn; Marcel Dekker series, 1995, pp 21-54.
- Martin A., Swarbrick J., Cammarata A. Physical Pharmacy- Physical Chemical Principles in the Pharmaceutical Sciences; 4th Edn; Lippincott, Williams and Wilkins, 2001, pp 285-290.
- Lachman L., Lieberman HA., Kanig JL. The Theory and Practice of Industrial Pharmacy; 3rd Edn; Varghese Publishing House, 1987, pp 760.
- P Sankpal, R Doijad, G Suryawanshi, P Patil, A Pathan, simple quantitative method development and validation of capecitabine in pure form and pharmaceutical dosage form by uv-spectroscopy, Inventi Rapid: Pharm Analysis & Quality Assurance.2012.
- Medikondu Kishore, M. Jayaprakash, T. Vijayabhaskarareddy. International Journal of Chem Tech Research. Vol.3, No.1, Page no. 63-69.
- Sreenivasa Rao T, Sukanya K, Chandanam Sreedhar, Akkamma HG, Sai Kumar S, Manogna, Development and Validation of New Analytical Methods for the Estimation of Capecitabine in Pharmaceutical Dosage Form, Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2012;3(3):713-721. Dhara R. Patel Method development, degradation pathway and kinetic of capecitabine International Journal of Pharmaceutical Chemistry and Analysis, July-September, 2018;5(3):133-140 140
- Mugunthu R. Dhananjeyan a, Jidong Liu a, Crystal Bykowski a, Jill A. Trendel a Jeffrey G. Sarver a, Howard Andob, Paul W. Erhardt. Journal of Chromatography A. 2007;1138:101–108.
- K. Ravi Kumar1, CH. M.M. Prasada Rao, CH. Babu Rao1, K.B. Chandrasekhar. International Journal of Chem Tech Research. 2010;2(1):307-311.
- Narendra Devanaboyina, Y. Sai Kishore, P. Pushpalatha, N. Mamatha, P. Venkatesh. International j of science invention today. Page no.21-30.
- P. Ravisankar, G. Devala Rao, M. Naveen Kumar, M. Krishna Chaitanyarary, and Scholars Research Library, 2013;5(3):249-260.
- Andre farkouh, Dagmar ettlinger, Johannes schueller, Apostolos Georgopoulos, Werner Scheithauer and Martin Czejka, Anticancer Research. 2010;30:5207-5212.
- L. Zuf´ıa, A. Aldaz, J. Giráldez, Simple determination of capecitabine and its metabolites by liquid chromatography with ultraviolet detection in a single injection. Journal of Chromatography B. 2004;809:51–
- Rajithakandimallai. Validated estimation of Capecitabine by HPTLC. IRJP. 2012;3(11):163-166.
- Pani Kumar AD, Venkata Raju Y, Sunitha G, Rama Krishna K, Ceema M and Venkateshwara Rao A. Development of Validated Stability Indicating RP-HPLC Method for the estimation of Capecitabine in Pure and Pharmaceutical Formulations. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011;2(1):175-181.
How to Cite This Article
Vancouver
Patel DR. Method development, degradation pathway and kinetic of capecitabine [Internet]. Int J Pharm Chem Anal. 2018 [cited 2025 Oct 30];5(3):133-140. Available from: https://doi.org/10.18231/2394-2797.2018.0021
APA
Patel, D. R. (2018). Method development, degradation pathway and kinetic of capecitabine. Int J Pharm Chem Anal, 5(3), 133-140. https://doi.org/10.18231/2394-2797.2018.0021
MLA
Patel, Dhara R.. "Method development, degradation pathway and kinetic of capecitabine." Int J Pharm Chem Anal, vol. 5, no. 3, 2018, pp. 133-140. https://doi.org/10.18231/2394-2797.2018.0021
Chicago
Patel, D. R.. "Method development, degradation pathway and kinetic of capecitabine." Int J Pharm Chem Anal 5, no. 3 (2018): 133-140. https://doi.org/10.18231/2394-2797.2018.0021